Cytokinetics

Cardiovascular Account Specialist - U.S. Sales, Manhasset, NY

Remote

Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, PharmaceuticalsIndustries

Position Overview

  • Location Type: Territory (New Hyde Park, NY, Great Neck, NY, Hempstead, NY)
  • Employment Type: Full Time
  • Salary: (Salary not provided)
  • Company: Cytokinetics

Cytokinetics is a late-stage, specialty cardiovascular biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which cardiac muscle performance is compromised. This role focuses on launching a novel cardiac myosin inhibitor for Hypertrophic Cardiomyopathy (HCM) within a specific territory. The ideal candidate will drive sales, build relationships with key stakeholders, and represent the company’s mission to address patients’ unmet needs.

Requirements

  • Education: Bachelor’s Degree required
  • Experience: 5+ years of experience in biotech/pharma sales.
  • Territory Ownership: Experience as a rep with sole ownership of the territory is highly preferred.
  • Preferred Experience: Cardiology, rare disease, or specialty product experience.
  • Launch Experience: Specialty product launch experience is a plus.

Responsibilities

  • Sales Performance: Deliver sales results and operate autonomously as the single point of accountability for the product launch within the assigned territory.
  • Account Planning: Develop territory-specific account plans, identifying, assessing, and prioritizing opportunities to meet customer needs.
  • Integrated Field Team Collaboration: Coordinate efforts with a local integrated field team including medical, payer, and patient navigation/support colleagues.
  • Subject Matter Expertise: Serve as a subject matter expert and resource to customers, providing clinically relevant disease and product information.
  • Demand Generation: Communicate approved resources to healthcare professionals (HCPs) to support HCM patients, including marketing materials, payer information, formulary coverage, and patient support services.
  • Strategic Thinking: Demonstrate strategic thinking and a proactive approach in supporting the company’s mission.

Application Instructions

  • (Application instructions not provided)

Company Information

Cytokinetics is a late-stage, specialty cardiovascular biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which cardiac muscle performance is compromised.

Core Values:

  • Patients are our North Star: Dedicated to benefiting patients and their caregivers.
  • Science is in our Soul: Committed to scientific excellence, integrity, and critical thinking.
  • We > Me: Strength lies in unity and diversity.
  • Make it Happen: Tenacity, resilience, and impactful results.

Skills

Biotech Sales
Pharmaceutical Sales
Cardiology
Rare Disease
Specialty Product Launch
Account Planning
Territory Management
Customer Relationship Building
Disease and Product Knowledge

Cytokinetics

Develops drugs for muscle function disorders

About Cytokinetics

Cytokinetics focuses on developing medicines that improve muscle function for patients with cardiovascular and neuromuscular diseases. Their products are small molecule drugs designed to either enhance or inhibit muscle function, tailored to specific therapeutic needs. The company has a pipeline of drugs, including omecamtiv mecarbil and reldesemtiv, which are in various stages of clinical trials. Unlike many competitors, Cytokinetics emphasizes rigorous scientific research and has conducted over 50 clinical trials to ensure the effectiveness of its treatments. The goal is to bring new therapies to market that address the unmet needs of patients suffering from conditions like heart failure, ALS, and HCM.

South San Francisco, CaliforniaHeadquarters
1998Year Founded
$58.4MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
501-1,000Employees

Risks

Increased competition could impact market share and profitability.
Potential delays in clinical trials could hinder drug commercialization.
Dependence on strategic partnerships may expose Cytokinetics to risks if challenges arise.

Differentiation

Cytokinetics focuses on muscle activators and inhibitors for cardiovascular and neuromuscular diseases.
The company has a robust pipeline including omecamtiv mecarbil and aficamten.
Cytokinetics engages in strategic partnerships, like with Sanofi, to expand market reach.

Upsides

Recent investments indicate strong interest in muscle activators and inhibitors.
Strategic partnerships, like with Sanofi, expand market reach and potential revenue.
Significant funding from Royalty Pharma supports commercial launch and R&D advancements.

Land your dream remote job 3x faster with AI